Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

Jens Lundgren, Abdel Babiker, Fred Gordin, Sean Emery, Gerd Fätkenheuer, Jean-Michel Molina, Robin Wood, James D Neaton, INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, Court Pedersen (Member of author group)

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalHIV Medicine
Volume16 Suppl 1
Pages (from-to)1-9
Number of pages9
ISSN1464-2662
DOIs
Publication statusPublished - Apr 2015

Cite this

Lundgren, J., Babiker, A., Gordin, F., Emery, S., Fätkenheuer, G., Molina, J-M., Wood, R., Neaton, J. D., INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, & Pedersen, C. (2015). Why START? Reflections that led to the conduct of this large long-term strategic HIV trial. HIV Medicine, 16 Suppl 1, 1-9. https://doi.org/10.1111/hiv.12227